Australian-first overdose management program launched

Burnet Institute

16 December, 2011

An Australian-first program distributing Naloxone – an opioid overdose reversal drug – to potential overdose victims was launched today in Canberra.

Naloxone will be available on prescription for those most at risk to overdose and their friends or family members trained to administer it.

Head of Burnet’s Alcohol and other Drug Research Group, Professor Paul Dietze was part of the Expanding Naloxone Availability in ACT (ENAACT) committee, and will have an ongoing role in evaluating the program.

“This program has the capacity to save lives. We’ve been calling for this type of intervention for years and it’s finally being introduced,” Professor Dietze said.

“I’m proud to have been part of this Australian-first and now other states and territories will be looking towards the ACT as an example and hopefully follow suit.”

The program was a collaboration with the Alcohol, Tobacco and Other Drug Association in ACT, ACT Health and the Canberra Alliance for Harm Minimisation and Advocacy.

CLICK HERE for more information about the Expanding Naloxone Availability in ACT program.

CLICK HERE for ABC 666 Canberra’s report on the program.

CLICK HERE to watch an ABC TV News story covering the launch.

Contact Details

For more information in relation to this news article, please contact:

Professor Paul Dietze

Co-Program Director, Disease Elimination




Subscribe to News

Subscribe to receive our latest news: